Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Imunon, Inc. Director's Dealing 2012

Sep 20, 2012

35124_dirs_2012-09-20_6e72ae13-9783-4f67-98c1-cf523de40477.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2012-09-20

Reporting Person: LINK MAX (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-09-20 Celsion Corporation Common Stock M 35000 $2.72 Acquired 296025 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-09-20 Option to purchase Celsion Corporation Common Stock $2.72 X 35000 Disposed 2019-01-19 Celsion Corporation Common Stock (35000) Direct

Footnotes

F1: The Director purchased Celsion Corporation Common Stock through the exercise of options from his January 11, 2009 Option Grant. These options were fully vested with an exercise price of $2.72 per share. The Director has no immediate intent to sell these newly acquired shares.